Clinical Trial: Application Research of Standardized Management Pathways for Cancer Pain Based on Hydromorphone Sustained-Release Tablets: A Multicenter Randomized Controlled Trial (China)

Posted On: 2026-09-17

China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Application Research of Standardized Management Pathways for Cancer Pain Based on Hydromorphone Sustained-Release Tablets: A Multicenter Randomized Controlled Trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132626

Registration Time: 2026/09/16

Type: Interventional study

Primary Sponsor: Shandong Provincial Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343654

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Application Research of Standardized Management Pathways for Cancer Pain Based on Hydromorphone Sustained-Release Tablets: A Multicenter Randomized Controlled Trial (China)